• 제목/요약/키워드: fasting treatment

검색결과 275건 처리시간 0.023초

산란계에서 급이환우가 산란계의 생산성과 계란의 품질 및 주요 장기에 미치는 영향 (Effects of Feeding Induced Molting on the Performance, Egg Quality, and Visceral Organs in Laying Hens)

  • 홍의철;나재천;유동조;장병귀;김학규;최양호;박희두;황보종
    • 한국가금학회지
    • /
    • 제34권3호
    • /
    • pp.197-205
    • /
    • 2007
  • 본 시험은 동물복지의 관점에서 국내 처음으로 급이 환우법을 실시하여, 절식에 의한 환우법과 환우 후 산란계의 생산성을 비교 검토하기 위해 수행하였다. 공시동물은 산란율 80% 이상, 평균 체중 $1.6{\pm}0.3\;kg$인 62주령 White Leghorn 81수를 이용하였다. 처리구는 환우처리하지 않은 미환우구를 대조구로, 절식 환우구와 급이 환우구를 시험구로, 총 3처리구를 설정하였으며, 처리구당 3반복, 반복당 9수씩 81수를 완전 임의 배치하였다. 환경 순치기 간으로서 환우 전 2주간 모든 공시계에게 동일한 산란 후기 사료(CP 15%, ME 2,700 kal)를 급여하였다. 환우 기간 중 급이 환우구 사료는 저단백질(CP 6.7%), 저에너지(ME 2,200 kal) 사료를 대조구와 동일한 양으로 급여하였다. 환우 기간은 급이 환우구 14일, 절식 환우구는 10일 동안 환우를 유도하였다. 산란율에서, 급이 환우구는 10일 동안 산란이 감소하다가 10일 후에 산란율이 0%가 되었으며, 절식구는 절식 $2{\sim}3$일째에 산란율이 0%가 되었다. 환우 기간이 끝난 후, 급이 환우구는 15일 후에 산란이 다시 시작되었으며, 비급이 환우구는 24일 후 산란이 다시 시작되었다. 계란 품질은, 환우 처리구에서 난중, 난각 두께, 난각 강도 및 하우 유니트가 개선되었으나(p<0.05), 난황색은 차이가 없었다(P>0.05). 전자현미경을 이용하여 환우를 유도 한 계란의 난각 조직은 환우 처리구의 난각 조직이 비환우구보다 치밀하였다. 환우가 끝난 후 간, 심장, 난포수란관의 무게를 비교한 결과 환우 처리구에서 무게가 크게 감소하였다(p<0.05). 결론적으로, 급이 환우가 동물 복지의 관점에서 절식 환우를 대신할 수 있을 것으로 사료되나, 금후 추가적인 연구가 요구된다.

The Analysis of the Effects of Physical Activity on Impaired Fasting Glucose in Adults Over 20 Years of Age

  • Joo-Won Yoon
    • 대한통합의학회지
    • /
    • 제11권2호
    • /
    • pp.181-196
    • /
    • 2023
  • Purpose : The purpose of this study was to investigate the effects of physical activity on impaired fasting glucose in adults aged 20 years or older. Methods : This study utilized raw data from the 8th National Health and Nutrition Examination survey (2019~2021). The subjects of this study were 5,344 adults aged 20 years or older who were confirmed to be free of diabetes. The control variables in this study model are health behavior characteristics (subjective health status, smoking, drinking), anthropometric characteristics (body mass index), and personal background characteristics (gender, age, income level, education level, marital status). As for the analysis method, the degree of physical activity was made into a dummy variable, and a probit model was used. Results : As a result of this study, compared to quartile 1 of the relative grip strength value obtained by dividing the grip strength by the body mass index (body mass index, kg, m2), fasting blood glucose levels were significantly higher in quartile 2 (.05, p<.01), quartile 3 (.04, p<.01), and quartile 4 (.04, p<.01). It was found that the probability of belonging to the normal category was higher than that of impaired fasting glucose. In addition, in the group of adults aged 20 or older who had a lot of aerobic and anaerobic physical activity, fasting blood sugar was more likely to be in the normal category. Conclusion : Based on the results of this study, it was suggested that diabetes should be managed through physical activity in the pre-diabetic stage, as prevention is important as well as treatment. From a practical point of view, muscle strength, such as grip strength, can be identified as a reliable indicator for identifying impaired fasting glucose.

장쇄 수산화 아세틸코에이 탈수소효소 결핍증에 대한 고찰 (Very Long Chain Acyl-coenzyme A Dehydrogenase Deficiency: A Review of Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment)

  • 강석진
    • 대한유전성대사질환학회지
    • /
    • 제22권1호
    • /
    • pp.21-27
    • /
    • 2022
  • Very long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency (VLCADD) leads to a defective 𝛽-oxidation, specifically during prolonged fasting, infection, or exercise. Patients with VLCADD usually suffer from cardiomyopathy, hypoketotic hypoglycemia, hepatic dysfunction, exercise intolerance, muscle pain, and rhabdomyolysis, and sometimes succumb to sudden death. VLCADD is generally classified into three phenotypes: severe early-onset cardiac and multiorgan failure, hypoketotic hypoglycemia, and later-onset episodic myopathy. Diagnostic evaluation comprises acylcarnitine analysis, genetic analysis, and VLCAD activity assay. In the acylcarnitine analysis, the key metabolites are C14:1, C14:2, C14, and C12:1. A C14:1 level >1 mmol/L strongly suggests VLCADD. Various treatment recommendations are available for this condition. Dietary management includes decreasing fat content, increasing medium-chain triglyceride levels, and decreasing fasting periods. Supplementation with L-carnitine is controversial. Triheptanoin (a seven-carbon fatty acid triglyceride) treatment demonstrates improvement of cardiac functions. Bezafibrate may improve the quality of life of patients with VLCAD.

PK/PD Modeling for Glucose-lowering Effect of Metformin in Korean Volunteers

  • Lee, Shin-Hwa;Yun, Min-Hyuk;Kwon, Kwang-Il
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
    • /
    • pp.307.1-307.1
    • /
    • 2003
  • Metfotrmin is a biguanide antihyperglycemic agent often used for the treatment of non-insulin dependent diabetics(NIDDM). Metformin lowers both fasting and postprandial plasma glucose concentrations by improving insulin sensitivity at hepatic and peripheral tissues. The pharmacokinetics and pharmacodynamics of metformin were studied in Korean healthy volunteers at fasting state over 10 hours. (omitted)

  • PDF

40, 50대 여성 비만도와 연령 별 대사증후군 위험인자 비교 (Comparison of the Metabolic Syndrome Risk Factor Prevalence Forty and Fifty Something Women)

  • 김희승;오정아
    • 대한간호학회지
    • /
    • 제37권4호
    • /
    • pp.453-458
    • /
    • 2007
  • Purpose: The purpose of this study was to compare metabolic syndrome (MS) risk factor prevalence by obesity and age in middle-aged women. Method: Two hundred and fifty-one subjects were recruited from the health promotion center of a tertiary care hospital in an urban city. MS was defined by the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III)(ATP III), and obesity was determined by body mass $index(BMI){\geq}25kg/m^2$. Results: The mean blood pressure, fasting glucose, total cholesterol, and triglyceride were significantly higher in the obese group than in the non-obese group. The prevalence of MS, hypertension, and impaired fasting glucose were significantly higher in the obese group than in the non-obese group. In the forties, blood pressure was significantly higher in the obese group than in the non-obese group. In the fifties, body fat, systolic blood pressure, fasting glucose, total cholesterol, and triglyceride were significantly higher in the obese group than in the non-obese group. Conclusions: These results show that the nurse should focus on the obese fifty year old female patients for improvement of the MS risk factors.

무염 사료의 급여가 유도환우에 미치는 영향 (Effects of Feeding Non-Salt Diet on the Induced Molting in Laying Hens)

  • 홍의철;나재천;유동조;김학규;정완태;이현정;김인호;황보종
    • 한국가금학회지
    • /
    • 제34권4호
    • /
    • pp.279-286
    • /
    • 2007
  • 본 시험은 동물복지의 관점에서 주정박과 무염 사료를 이용하여 급이 환우법을 실시하고, 절식에 의한 환우법과 환우 후 산란계의 생산성을 비교 검토하기 위해 수행하였다. 공시동물은 산란율 80% 이상, 평균 체중 $1.8{\pm}0.1kg$인 67주령 White Leghorn 108수를 이용하였다. 처리구는 환우처리 하지 않은 미환우구(대조구)로, 비급이 환우구(9일간 절식, 그 후 19일간 환우 사료)와 급이 환우구(주정박, 무염 사료)를 시험구로, 총 4처리구를 설정하였으며, 처리구당 3반복, 반복당 9수씩 108수를 완전 임의 배치하였다. 환경 순치 기간으로서 환우 전 2주간 모든 공시계에게 동일한 산란 후기 사료(CP 15%, ME 2,700 kal)를 급여하였다. 환우 기간은 전처리구에서 28일 동안 환우를 유도하였다. 산란율에서, 환우 사료 급이구는 환우 처리 후 6일째부터 12일 동안 산란율이 감소하였으며, 12일 후에 산란율이 0%가 되었다. 무염 사료 급이구는 환우처리 후 5일째부터 10일 동안 산란율이 감소하였으며, 10일 후에 산란율이 0%가 되었다. 비급이 환우구는 절식 2일째부터 산란율이 급격히 감소하여 6일째에 0%가 되었다. 환우 시험 종료 후 산란 후기 사료를 다시 급여하였을 때, 환우 사료와 무염 사료 급이구는 급여 12일째 산란이 다시 시작되었으며, 비급이 환우구는 16일째 산란이 다시 시작되었다. 체중 변화를 보면, 급이 환우구에서는 환우 사료를 급여한 경우, 28일째 48.3%까지 체중의 감량이 있었으나, 무염사료는 21.4%의 체중 감량을 보였다. 비급이 환우구에서는 절식시킨 9일까지는 체중의 급격한 감소가 있었으나, 9일 이후 환우 사료를 급여하는 19일 동안에는 약간의 증체가 일어났다. 환우가 끝난 후 간, 심장, 난포수란관의 무게를 비교 한 결과, 환우처리구에서 무게가 크게 감소하였다(p<0.05). 계란 품질은 환우 처리구에서 난중, 난각 두께, 난각 강도 및 하우유니트가 개선되었으나(p<0.05), 난황색은 차이가 없었다(P>0.05). 전자 현미경을 이용하여 환우를 유도한 계란의 난각 조직은 환우 처리구의 난각 조직이 비환우구보다 치밀하였다. 결론적으로, 급이 환우가 동물 복지의 관점에서 절식환우를 대신할 수 있을 것으로 사료되나, 금후 추가적인 연구가 요구된다.

Elevated Serum Insulin is an Independent Risk Factor for Hepatocellular Carcinoma: A Case Control Study from Nepal

  • Gupta, Satrudhan Pd;Mittal, Ankush;Sathian, Brijesh;Jha, Dipendra Kumar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7331-7333
    • /
    • 2013
  • Aim: To investigate associations of fasting insulin and glucose levels in serum with hepatocellular carcinoma risk. Materials and Methods: This hospital based study was carried out using data retrieved from the register maintained in the Department of Biochemistry of the Nepalese Army Institute of Health Sciences, between 1st December, 2011 and 31st June, 2013. The variables collected were age, fasting plasma glucose, fasting plasma insulin and ALT. Quantitative determination of human insulin concentrations was accomplished by chemiluminescence enzyme immunoassay. Results: Of the total 220 subjects enrolled in our present study, 20 cases were of HCC and 200 were healthy controls. The maximum number of cases of hepatocellular carcinoma in category cutpoints of fasting insulin levels fell in the range of >6.10 ${\mu}U/ml$. The highest insulin levels (>6.10 ${\mu}U/ml$) were seen to be associated with an 2.36 fold risk of HCC when compared with fasting insulin levels of (<2.75 ${\mu}U/ml$). Furthermore, the insulin levels (2.75-4.10 ${\mu}U/ml$) of category cutpoints also conferred a 1.57 fold risk for HCC when compared with lowest fasting insulin levels of (<2.75 ${\mu}U/ml$). Conclusions: The effect of an insulin level in increasing HCC risk appeared consistent, influencing incidence, risk of recurrence, overall survival, and treatment-related complications in HCC patients.

다낭성난소증후군 환자에서 Pioglitazone이 인슐린 민감도, 난소 기능, 난소 기질 내 혈류에 미치는 영향 (Effects of Pioglitazone on Insulin Sensitivity, Ovarian Function and Intraovarian Stromal Blood Flow in Women with Polycystic Ovary Syndrome)

  • 이향아;김정훈;최정원;박선정;이수정;최은선;김성훈;채희동;손영수;강병문
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제32권2호
    • /
    • pp.155-164
    • /
    • 2005
  • Objective: This study was performed to investigate the effects of pioglitazone, an insulin sensitizing agent, on insulin resistance, ovarian function and intraovarian stromal blood flow in patients with polycystic ovarian syndrome (PCOS). Material and Methods: Thirty patients with PCOS, aged 18~34 years, were recruited. Criteria for diagnosis of PCOS were as defined in 2003 Rotterdam consensus. They were treated for 6 months with pioglitazone at a dose of 30 mg/day orally. The hormonal blood profile, fasting serum glucose levels, a glycemic response to 75 g oral glucose tolerance test (OGTT), and an ovarian stromal artery (OSA) blood flow were assessed at baseline and after 6 months of treatment. Results: Eighteen (60.0%) of 30 patients treated with pioglitazone demonstrated a spontaneous ovulation After pioglitazone treatment, fasting insulin concentrations, serum glucose levels after 75 g OGTT significantly decreased (p=0.001, p=0.04, respectively), and fasting glucose to insulin (G/I) ratio significantly increased (p<0.001). The pioglitazone treatment induced a significant reduction in serum LH, testosterone (T) and free T levels (p<0.001, p=0.02, p=0.002, respectively). The resistance index (RI) values of OSA significantly increased after treatment (p<0.001). In analyzing pioglitazone-treated patients according to their body mass index (BMI), nonobese group as well as obese group showed a significant improvement in fasting G/I ratio (p<0.01). The pioglitazone treatment induced a significant reduction in serum LH and free T levels in nonobese group (p<0.001, p<0.05, respectively) as well as obese group (p=0.001, p<0.05, respectively). The RI values of OSA significantly increased in both nonobese and obese groups after pioglitazone treatment (p<0.001, p=0.003, respectively). Conclusions: Pioglitazone could ameliorate the glycoinsulinemic metabolism, and this beneficial effects of this drug could improve the endocrine-reproductive condition associated with the decrease of ovarian stromal artery blood flow, in both nonobese and obese patients with PCOS.

Growth Performance, Plasma Fatty Acids, Villous Height and Crypt Depth of Preweaning Piglets Fed with Medium Chain Triacylglycerol

  • Chwen, Loh Teck;Foo, Hooi Ling;Thanh, Nguyen Tien;Choe, D.W.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제26권5호
    • /
    • pp.700-704
    • /
    • 2013
  • A study was conducted to investigate the effects of feeding medium chain triacylglycerol (MCT) on growth performance, plasma fatty acids, villus height and crypt depth in preweaning piglets. A total of 150 new born piglets were randomly assigned into one of three treatments: i) Control (no MCT); ii) MCT with milk (MCT+milk); iii) MCT without milk (MCT+fasting). Body weight, plasma fatty acid profiles, villus height and crypt depth were measured. Final BW for the Control and MCT+fasting was lower (p<0.05) than MCT+milk. The piglets fed with MCT regardless of milk provision or fasting had greater medium chain fatty acids (MCFA) than the Control. In contrast, the Control had greater long chain fatty acid (LCFA) and unsaturated fatty acid (USFA) than the MCT piglets. The piglets fed with MCT regardless of milk provision or fasting had higher villus height for the duodenum and jejunum after 6 h of feeding. Similar observations were found in piglets fed with MCT after 6 and 8 days of treatment. This study showed that feeding MCT to the piglets before weaning improved growth performance, with a greater concentration of MCT in blood plasma as energy source and a greater height of villus in duodenum, jejunum and ileum.

Guar gum을 첨가한 쑥설기가 Type-ll 당뇨환자의 혈액성분에 미치는 영향 (Effects of Guar Suksolgi on the Blood Glucose and Lipids in Type-ll Diabetic Subjects)

  • 장유경
    • 대한가정학회지
    • /
    • 제33권1호
    • /
    • pp.169-180
    • /
    • 1995
  • To determine the effects of guar suksolgi on blood glucose and lipids in type-ll diabetic subjects, a piece of guar suksolgi(36.3g, 54Kcal) was administered to eight patients for 3 weeks every meal. No significant differences occured indietary intakes and body weight before and after the treatment. Fasting blood glucose levels were decreased from 132.38mg/dI to 114.75mg/dI after the treatment, but not statistically significant. Blood TG levels were increased from 159.13mg/dI to 175.00mg/dI after the treatment, but not statistically significant. Excluding one patient who had extremely high TG level, blood TG levels tended to be decreased from 148.00mg/dI to 121.00mg/dI. TC LDL-c, HDL-c levels were decreased after the treatment, but not statistically significant. HbAIC concentrations were decreased from 8.54mg/kI to 7.80mg/dI after the treatment, but not statistically significant. In the case of three patients who had had normal fasting blood glucose levels, blood glucose levels tended to be decreased at postprandial 30, 60 minutes, and blood insulin levels tended to be decreased at postprandial 30, 60, 90, 120 minutes, although none of the levels were statistically significant. Therefore, if guar suksolgi is adinistered to type-ll diabetic subjects being more hyperglycemic than our patients, their blood glucose and lipids will be decreased significantly.

  • PDF